The clinical course and hematologic changes of three dogs with lymphocytosis of cells morphologically resembling large granular lymphocytes are presented. Hemograms from all dogs showed leukocytosis with marked lymphocytosis. Lymphocytes were characterized by abundant basophilic cytoplasm containing distinct granules which varied in size and number. Electron microscopically the granules were membrane-bound with an electron-dense core. Lymphocytes from one dog were positive for alkaline phosphatase activity, and lymphocytes from another dog were positive for alpha naphthyl butyrate esterase activity. Lymphocytes from one dog were positive for surface receptors for the crystalline fraction portion of gamma immunoglobulins.
Large granular lymphocytes (LGL's) in people represent a morphologically distinct population of peripheral blood lymphocytes characterized by abundant pale blue cytoplasm that contains prominent azurophilic granules.zo These cells represent about 10% of normal peripheral blood lymphocytes and are responsible for the majority of natural killer cell activity and antibody-dependent cytotoxicity expressed by peripheral blood mononuclear cek3x4 Most LGL's have surface receptors for the crystalline fraction portion of gamma immunoglobulins and express at least one T lymphocyte-associated cell surface antigen, and, therefore usually are included as a subset of Ty lymphocytes. However, because LGL's share phenotypic and functional properties with both T cells and myelomonocytic cells, their precise lineage derivation remains ~nresolved.~,~ There have been numerous reports of human patients with lymphoproliferative disorders involving LGL's.~,'~,'~ Lymphoma involving LGL's has been described in one cat,6 and LGL leukemia is a well-recognized spontaneous neoplasm of Fischer rats.I9 In this report, we describe three dogs with lymphocytosis involving cells which morphologically resemble LGL's.
Materials and Methods
Clinical records from three dogs with a diagnosis of lymphocytosis of large granular lymphocytes (LGL's) were reviewed. Hematologic diagnosis was made by examining Wright-Giemsa-stained films of peripheral blood and bone marrow and identifying a monomorphic population of lymphocytes with morphologic characteristics of LGL's. Complete blood counts were done on whole blood anticoagulated with ethylenediaminetetraacetate (EDTA) using a model S Plus IV Analyzer (Coulter Electronics, Hialeah, FL). Cytochemical stains for chloracetate esterase, alpha naphthyl butyrate esterase, alkaline phosphatase, Sudan black B, and acid phosphatase activities were done on both peripheral blood and bone marrow films using commercially available staining kits (Sigma Chemical Company, St. Louis, MO). Routine techniques were used for periodic acid-Schiff (PAS) and toluidine blue stains. One hundred cells with lymphoid morphology were evaluated for a positive staining reaction.
Peripheral blood mononuclear cells of one dog were evaluated for the presence of surface receptors for the crystalline fraction (Fc) portion of gamma immunoglobulins (IgG) using rosette-forming assays as previously described. Erythrocyte antibody (EA) rosettes were prepared by incubating a 1.25% suspension of sheep erythrocytes with a subagglutinating dilution of the 7s fraction of rabbit anti-sheep erythrocyte serum at 37 C for 15 min. Peripheral blood mononuclear cells (0.1 ml) enriched by density gradient centrifugation (Lymphocyte Separation Medium, Litton Bionetics, Kensington, MD) were incubated with 10 pl of EA for 25 min at 37 C, centrifuged at 150 x g for 7 min, and examined for rosette formation.
Peripheral blood mononuclear cells from one dog were fixed in 3% glutaraldehyde in 0.1 M cacodylate buffer, postfixed in 1% OsO,, dehydrated in ethanol, and embedded in Epon resin. Representative thin sections were contrasted with uranyl acetate and lead nitrate and examined with a Philips EM 300 electron microscope.
Peripheral blood films from ten age-matched healthy dogs with no hematologic abnormalities were examined to determine the percentage of lymphocytes with LGL morphology. Fifty to 100 lymphocytes were counted, and the percentage of lymphocytes with LGL morphology was determined. Peripheral blood films from the three dogs with lymphocytic leukemia also were examined to determine the percentage of lymphocytes with granules. 158 * RDW = red cell distribution width.
Results
There were two spayed female dogs (a 10-year-old Irish setter mix and a 13-year-old collie mix) and one castrated male dog (a 12-year-old standard poodle) which were presented with variable clinical signs including anorexia, lethargy, depression, dyspnea, polydipsia, and a nonproductive cough. All three dogs had mild to moderately enlarged peripheral lymph nodes. Other abnormalities detected on physical examination included pleural effusion with a cranial mediastinal mass in one dog and hepatosplenomegaly with mild icterus in another dog.
The initial hemograms for each dog are shown ( Table  1 ). The most remarkable abnormality was leukocytosis (67.4, 97.6, and 138.4 x lo9 nucleated cells/liter; reference values, 6.5-1 9.0 x 109/liter) characterized by marked lymphocytosis (53.2, 94.7, and 127.3 x lo9/ liter; reference values, 1.2-5.2 x 109/liter). Lymphocytes represented 79, 80, and 97% of the peripheral blood nucleated cells from the initial hemogram. The lymphocytes were large (10-20 pm in diameter) and had round, oval, indented, or irregularly shaped nuclei with finely stippled chromatin ( Fig. 1 ). There was abundant lightly basophilic cytoplasm containing distinct granules which varied in number (few to many), size (small to large), and staining quality (lightly azurophilic to basophilic). The percentage of peripheral blood lymphocytes that contained cytoplasmic granules varied markedly among the dogs and among mul-tiple blood samples from the same dog. Typically, 25-75% of the lymphocytes contained cytoplasmic granules. The percentage of lymphocytes with large granular lymphocyte (LGL) morphology in peripheral blood from healthy age-matched dogs was 0-1 0%. Nonregenerative anemia was present initially or during the clinical course in all dogs. One dog had neutropenia and thrombocytopenia at presentation, one dog had thrombocytopenia and normal numbers of neutrophils, and one dog developed neutropenia and thrombocytopenia terminally.
The bone marrow was hypercellular in all dogs. Of all cells, 25-90% were lymphocytes, which morphologically resembled the LGL's in the peripheral blood.
A diagnosis of lymphocytosis of LGL's was made based on films of peripheral blood and bone marrow. One dog (Dog 1) was treated with multiple agent chemotherapy which resulted in clinical and hematologic remission that lasted 82 days, at which time the dog was euthanized. A necropsy was not done. Another dog (Dog 2) was euthanized 5 days after presentation when no clinical or hematologic remission was noted after low dose cytosine arabinoside therapy. No necropsy was done. In the third dog (Dog 3), clinical and hematologic remission for LGL lymphocytosis was achieved for 18 months with multiple agent chemotherapy, after which time the dog presented with marked generalized lymphadenopathy and splenomegaly. The histopathologic diagnosis of the spleen and a popliteal lymph node was diffuse immunoblastic lymphoma. The peripheral blood lymphocyte count was within normal limits at this time. Remission of the lymphoma was achieved with chemotherapy. Twenty-one months af-ter the initial diagnosis of LGL lymphocytosis the dog presented for progressive deterioration and bloody diarrhea. The dog did not respond to supportive therapy and was euthanized. A necropsy was not done.
The results of cytochemical and histochemical stains of the bone marrow were compiled ( Table 2) . Staining of peripheral blood films showed similar results. Most staining results were negative, but lymphoid cells from one dog were strongly positive for alkaline phosphatase activity, and cells from another dog were focally positive for alpha naphthyl butyrate esterase activity.
Cells from one dog (Dog 3) were positive (82%) for surface receptors for the crystalline fraction (Fc) portion of gamma immunoglobulins (IgG). Cells from the other two dogs were not evaluated for surface receptors.
Peripheral blood cells from only one dog (Dog 1) were available for electron microscopic evaluation. Large membrane-bound granules with an electrondense core were present in the cytoplasm of occasional lymphocytes (Fig. 2) . The majority of lymphocytes did not contain these granules, but instead had multiple prominent mitochondria.
Discussion
In this report we describe three dogs with lymphocytosis involving cells which resemble Ty lymphocytes with large granular lymphocyte (LGL) morphology. The dogs in this study were 10, 12, and 14 years old, which correlates with the median age of 58 years for 3 5 human patients with Ty lymphoproliferative disease.I5 Leukemia of LGL's also occurs in aged Fischer rats. 19 The clinical course in humans with LGL lymphoproliferative disease is heterogene~us.'.~ Most reported cases of human LGL lymphocytosis show little or no progression of the lymph~proliferation.~ However, there are cases of LGL lymphocytosis with a progressive clinical course that behave more like a malignant proce~s,~.*J~ and LGL leukemia in Fischer rats clinically is an aggressive disease. l 9 Moreover, clonal rearrangements of the gene for the beta chain of the T cell receptor have been reported in LGL's from some patients with Ty lymphoproliferative di~ease.~ One dog described in this report followed a prolonged clinical course suggestive of chronic lymphoproliferative disease, whereas the clinical course in two dogs was more progressive.
Clinical signs in dogs with LGL lymphocytosis were relatively nonspecific. Mild to moderate enlargement of lymph nodes in three dogs and hepatosplenomegaly in one dog differ from the occasional splenomegaly and absence of lymphadenopathy seen in humans with LGL lymphoproliferative d i s e a~e .~J~,~~ Splenomegaly is marked in Fischer rats with LGL 1e~kemia.I~ Lymph nodes were not evaluated either cytologically or histologically to determine whether there was neoplastic infiltration with LGL's. The marked lymphadenopathy and splenomegaly seen late in the clinical course in the dog with chronic lymphoproliferative disease may have Table 2 . Cytochemical staining of bone marrow cells from three dogs with lymphocytosis of large granular lymphocytes. represented the development of lymphoma involving a different population of lymphocytes. No granules were seen in the cytoplasm of these cells.
The marked LGL lymphocytosis in dogs in this report is similar to that seen in humans with LGL lymphoproliferative disease and in rats with LGL leukemia.4J9 The high percentage of lymphocytes (25 to 75Yo) with LGL morphology in dogs with LGL lymphocytosis is in marked contrast to the hemograms from agematched healthy normal dogs (0 to 10% lymphocytes with LGL morphology).
LGL's comprise 10% of normal peripheral blood lymphocytes in man but greater than 50% of peripheral blood lymphocytes in patients with LGL lymphoproliferative d i~e a s e .~.~ Humans with LGL lymphocytosis frequently have severe neutropenia and many also have mild to moderate anemia.3 Two dogs discussed in this report were neutropenic, and all presented with or developed nonregenerative anemia. Thrombocytopenia in two dogs with LGL lymphocytosis is atypical for the disease in man, but has been reported in several cases with LGL lympho~ytosis.~J~J~ The mechanism for these hematocytopenias is unknown, although defects in B cell immunoregulation have been proposed."
Bone marrow often is infiltrated with LGL's in humans with Ty lymphoproliferative di~ease.~ Bone marrow in the three dogs discussed in this report was infiltrated with 25 to 95% LGL's. Bone marrow infiltration could account for some of the cytopenias seen in both human and canine patients with LGL lymphocytosis.
Although there are no unequivocal markers that clearly distinguish the LGL population from other lymphoid cells, four main criteria have been used to identify LGL's: (1) morphology, (2) histochemistry, (3) cell surface antigens, and (4) function. 15 The LGL's from three dogs with LGL lymphocytosis morphologically resemble those described for human patients with LGL lymphocyto~is~ and for rats with LGL 1e~kemia.I~ The cytoplasmic granules characteristic of LGL's can vary markedly in number, shape, and size,3 as was shown for the dogs with LGL lymphocytosis. The elec-tron microscopic structure of the LGL granules from one dog resembled dense core granules described for human and canine LGL granules.'OJ8 No granules with parallel tubular array structure described in humans12 were seen in LGL's from this dog.
The histochemical staining pattern for lymphocytes from the three dogs with LGL lymphocytosis differed from what has been reported for human LGL's. The LGL's from humans are strongly positive for acid phosphatase and /3 glucuronidase a~tivities.~ The LGL's from only one dog were tested for acid phosphatase activity and were negative. None of the dog LGL's were tested for fi glucuronidase activity. LGL's from the cat with LGL lymphoma were only faintly positive for acid phosphatase activity, and LGL's from rats with LGL leukemia have variable expression of acid phosphatase and / 3 gluc~ronidase.~J~ The LGL's from one dog were strongly positive for alkaline phosphatase activity, and the LGL's from another dog were focally positive for alpha naphthyl butyrate esterase (ANBE) activity. Alkaline phosphatase activity has not been reported for human LGL's, whereas focal ANBE activity has been described.2 These differences in histochemical staining pattern among LGL's from dogs, humans, rats, and cats may reflect species differences as has been reported for other types of peripheral blood cells5
There is marked variation in the cell surface phenotype of LGL's in human^.^.^ However, a high proportion of cells from most patients with LGL lymphoproliferative disease have receptors for the crystalline fraction (Fc) portion of gamma immunoglobulins (IgG).4 Natural killer cells from healthy dogs also have receptors for the Fc portion of IgG.I6 The LGL's from one dog with LGL lymphocytosis displayed surface receptors for Fcy.
The hallmark of human LGL's in cellular functional assays is their natural killer (NK) and antibody-dependent cell-mediated cytotoxicity (ADCC) activi-tiesL3 The lymphocytes from the dogs with LGL lymphocytosis were not evaluated for NK or ADCC activity. However, cells with NK and ADCC activities from healthy dogs have cytoplasmic granules characteristic of both human LGL's and the LGL's from dogs with LGL lymphocytosis described in this report.'O We have described the clinical course and hematologic changes in three dogs with lymphocytosis involving cells which morphologically resemble LGL's. Further evaluation of the histochemical, cell surface antigen, and functional characteristics of lymphocytes from other dogs with LGL lymphocytosis will be useful in understanding the pathogenesis of this disease and in managing the clinical course in these patients. 
